Brivaracetam

Brivaracetam, a potent anticonvulsant, is used primarily for the treatment of partial-onset seizures in epilepsy patients aged four and older. It binds strongly to synaptic vesicle protein 2A (SV2A), reducing the release of excitatory neurotransmitters, which may help control seizure activity. It is known for its superior efficacy compared to other antiepileptic drugs, such as levetiracetam.

Amber Lifesciences, a certified global supplier based in India, offers high-quality Brivaracetam to meet your research, development, and commercial needs. Sourced through a trusted network of manufacturers and suppliers, we ensure compliance with stringent regulatory standards and provide detailed technical data for your evaluation.